# Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Main Trial)

> **NCT02192424** · PHASE3 · COMPLETED · sponsor: **Mount Sinai Hospital, Canada** · enrollment: 109 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Metformin alone
- **DRUG:** Metformin + Intermittent Insulin Therapy

## Key facts

- **NCT ID:** NCT02192424
- **Lead sponsor:** Mount Sinai Hospital, Canada
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2020-08
- **Final completion:** 2020-09
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2020-10-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02192424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02192424, "Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Main Trial)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02192424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*